Phase l Study – Boltbody™ Immune-Stimulating Antibody Conjugates (ISAC)
Randy Schatzman, CEO at Bolt Biotherapeutics, Inc., discusses how Bolt is developing drugs to turn cold tumors "hot" to achieve an anti-tumoral activity...
3315 articles
Randy Schatzman, CEO at Bolt Biotherapeutics, Inc., discusses how Bolt is developing drugs to turn cold tumors "hot" to achieve an anti-tumoral activity...
Rob Wiley, discusses Formstack, a secure productivity platform that digitizes information, automates workflows and reforms processes and how the value o...
Mark Bruce discusses the geographic disproportion of new COVID-19 cases, how the U.S. Learn more on Health Professional Radio.
Rich Daly, Chief Operating Officer at Beyond Spring Inc., a biopharmaceutical company, discusses Plinabulin, the company's lead asset currently in late-...
Stuart Hershman, Orthopaedic Spine Surgeon at Massachusetts General Hospital, discusses his presentation from the American Academy of Orthopaedic Surgeo...
Syneos Health Medical Director and critical care pulmonologist Dr. Learn more on Health Professional Radio.
Eddie Fatakhov, MD, a board-certified internist from Atlanta discusses the efficiency and effectiveness of Far-UV Light and how it is able to kill the C...
Tracy Frech, a rheumatologist from the University of Utah discusses her work with Corbus Pharmaceuticals to address systemic sclerosis (SSc) through a d...
Rebecca Kasen, advocacy director at Community Access Unlimited (CAU) in New Jersey discusses what the month of March as Developmental Disability Awarene...
Jacqueline Jones, MD, one of America's Top Doctors™, discusses concerns about coronavirus from the parent/child perspective and her latest book "Medic...